{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
J B Chemicals & Pharmaceuticals Ltd
How has been the historical performance of J B Chemicals &?
J B Chemicals & has shown consistent growth in net sales and profitability, with net sales increasing from 1,643.20 Cr in Mar'19 to 3,917.99 Cr in Mar'25, and profit after tax rising from 193.97 Cr to 659.58 Cr during the same period. The company also improved its operational efficiency and maintained a solid balance sheet, with total assets growing significantly.
Are J B Chemicals & latest results good or bad?
J B Chemicals' latest results show strong year-on-year growth in net sales and profit, with improved margins and a solid balance sheet. However, recent revenue fluctuations and sector challenges suggest a need for cautious monitoring of future performance.
J B Chemicals Q2 FY26: Margin Expansion Drives 19% Profit Growth Despite Flat Sales
J B Chemicals & Pharmaceuticals Ltd., a Mumbai-based mid-sized pharmaceutical company with a market capitalisation of ₹28,515 crores, delivered a mixed performance in Q2 FY26, reporting net profit of ₹207.82 crores—a modest 2.69% increase quarter-on-quarter but a robust 19.05% surge year-on-year. The company's stock has responded positively to the results, trading at ₹1,826.65 as of November 11, 2025, up 7.62% over the past week and 9.09% over the month, significantly outperforming the broader market.
Why is J B Chemicals & falling/rising?
As of 10-Nov, J B Chemicals & Pharmaceuticals Ltd is seeing a price increase to 1,813.40, up 6.57%, with strong short-term performance and positive operational metrics. However, year-to-date, it lags behind the Sensex, and investor participation has notably decreased.
Is J B Chemicals & technically bullish or bearish?
As of November 7, 2025, J B Chemicals & shows a mildly bullish trend driven by daily moving averages, despite caution from weekly and monthly indicators like MACD and KST, while volatility remains low according to Bollinger Bands.
J B Chemicals & Pharmaceuticals Shows Mixed Technical Trends Amid Market Evaluation Revision
J B Chemicals & Pharmaceuticals has recently revised its evaluation amid current market dynamics. The stock, priced at 1,700.00, has seen an 8.62% decline over the past year, contrasting with the Sensex's gain. Notably, the company has achieved significant long-term returns, outperforming the Sensex over five and three years.
Is J B Chemicals & technically bullish or bearish?
As of November 7, 2025, J B Chemicals & shows a mildly bullish trend driven by daily moving averages, despite mixed signals from longer-term indicators like MACD and KST, and a lack of volatility indicated by Bollinger Bands.
Is J B Chemicals & technically bullish or bearish?
As of 7 November 2025, J B Chemicals & shows a mildly bullish trend due to bullish daily moving averages, despite bearish signals from weekly and monthly MACD and KST readings.
Is J B Chemicals & technically bullish or bearish?
As of November 6, 2025, J B Chemicals & shows a neutral trend with mixed signals, as the weekly MACD is bearish, daily moving averages are mildly bullish, and both Bollinger Bands and RSI indicate sideways movement.
J B Chemicals & Pharmaceuticals Faces Mixed Technical Trends Amid Market Evaluation Revision
J B Chemicals & Pharmaceuticals, a small-cap firm in the Pharmaceuticals sector, has seen its stock price decline recently, contrasting with a modest gain in the Sensex. Despite a 10.65% drop over the past year, the company boasts impressive long-term performance, achieving a 1,142.83% return over the last decade.
Is J B Chemicals & technically bullish or bearish?
As of November 3, 2025, J B Chemicals & shows a mildly bullish trend driven by daily moving averages, despite mixed signals from weekly and monthly MACD and KST indicators.
J B Chemicals & Pharmaceuticals Shows Mixed Technical Trends Amid Market Fluctuations
J B Chemicals & Pharmaceuticals has recently revised its evaluation amid changing market conditions. The stock price has risen from the previous close, with notable fluctuations over the past year. While it has shown varied performance against the Sensex, the company has significantly outperformed it over the last three years.
Is J B Chemicals & technically bullish or bearish?
As of 31 October 2025, J B Chemicals & shows a neutral trend with mixed indicators, as weekly and monthly metrics are bearish while daily moving averages and OBV suggest mild bullishness, resulting in an overall sideways market stance.
J B Chemicals & Pharmaceuticals Faces Mixed Technical Trends Amid Stock Decline
J B Chemicals & Pharmaceuticals has seen a recent price decline, reflecting mixed technical indicators. While the stock has struggled over the past year and year-to-date, it has shown strong long-term performance, significantly outperforming the Sensex over three and five years, indicating resilience in navigating market dynamics.
Is J B Chemicals & technically bullish or bearish?
As of October 31, 2025, J B Chemicals & has shifted to a neutral technical stance with mixed signals, showing mildly bearish indicators on weekly and monthly charts, while daily moving averages and OBV indicate mild bullishness, leading to a cautious outlook.
Is J B Chemicals & technically bullish or bearish?
As of 31 October 2025, J B Chemicals & exhibits a neutral technical trend with mixed signals, showing mildly bearish indicators on weekly and monthly charts, while daily moving averages suggest a weak bullish trend.
J B Chemicals & Pharmaceuticals Shows Mixed Technical Trends Amid Market Evaluation Revision
J B Chemicals & Pharmaceuticals has recently revised its evaluation amid changing market conditions. The stock price has seen a slight increase, though it has declined over the past year. Despite recent trends, the company has shown impressive long-term growth, significantly outperforming the Sensex over the last decade.
Is J B Chemicals & technically bullish or bearish?
As of 28 October 2025, J B Chemicals & shows a neutral technical stance with mixed signals, indicating a shift from mildly bullish to sideways, as bearish indicators outweigh weak bullish signals.
J B Chemicals & Pharmaceuticals Faces Mixed Technical Trends Amid Market Challenges
J B Chemicals & Pharmaceuticals has recently revised its evaluation amid challenging market conditions, with its stock price at 1,688.20. Despite a 10.03% decline over the past year, the company has demonstrated significant long-term growth of 1,058.48% over the last decade, indicating resilience in a complex market landscape.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
